logo

Amag Pharmaceuticals Inc. (AMAG)



Trade AMAG now with
  Date
  Headline
10/11/2019 8:06:04 AM AMAG Pharma Announces Publication Of Phase 3 Vyleesi Data In Obstetrics & Gynecology
10/8/2019 8:05:16 AM AMAG Pharma Announces Settlement Agreement With Caligan Partners
9/26/2019 8:17:52 AM Caligan Partners Issues Letter To AMAG Shareholders; Nominates Directors
2/7/2019 7:27:08 AM AMAG Pharmaceuticals Q4 Loss Per Share $0.64 Vs EPS $0.10 Prior Year
1/17/2019 8:04:17 AM AMAG Completes Acquisition Of Perosphere Pharmaceuticals
1/7/2019 7:18:17 AM AMAG Pharma Q4 Expects Total Revenues From Cont. Opns To Be $85 Mln And $90 Mln
11/1/2018 7:23:24 AM AMAG Pharmaceuticals Q3 Net Loss From Cont Ops $64.7 Mln Or $1.88/Shr Vs Loss $155.7 Mln Or $4.41/Shr Last Year
9/26/2018 6:32:21 AM AMAG Pharmaceuticals Acquires Global Rights To Develop And Market Digoxin Immune Fab
9/13/2018 7:34:27 AM Palatin Technologies Q4 Net Income Of $11.8 Mln Or $0.06/shr Vs $13.3 Mln Or $0.07/shr Prior Year
9/6/2018 8:05:41 AM AMAG Pharmaceuticals Pays Off $475 Mln Of Senior Secured Notes
8/6/2018 7:32:34 AM AMAG Pharmaceuticals Appoints Brian Robinson SVP, Medical Affairs
8/2/2018 7:23:52 AM AMAG Pharma Q2 Loss Per Share $0.58 Vs Loss $0.40 Last Year
6/15/2018 7:04:33 AM AMAG Pharmaceuticals, Trading Expected To Resume At 7:30 AM ET
6/15/2018 7:03:03 AM AMAG Pharma To Divest Cord Blood Registry To GI Partners For $530 Mln; Deal Expect To Close In Q3
6/15/2018 7:02:50 AM AMAG Pharmaceuticals, Trading Halted Pending News
  
 
>